Business Description
NeuroOne Medical Technologies Corp
NAICS : 339113
SIC : 5047
7599 Anagram Dr., Eden Prairie, MN, USA, 55344
Description
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram(cEEG) and stereoelectrocencephalography(sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 49.31 | |||||
Equity-to-Asset | 0.93 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.02 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 12.27 | |||||
Beneish M-Score | -2.17 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 68.35 | |||||
9-Day RSI | 75.15 | |||||
14-Day RSI | 74.8 | |||||
6-1 Month Momentum % | -67.74 | |||||
12-1 Month Momentum % | -78.34 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 16.6 | |||||
Quick Ratio | 16.32 | |||||
Cash Ratio | 15.89 | |||||
Days Inventory | 222.03 | |||||
Days Sales Outstanding | 86.08 | |||||
Days Payable | 685.96 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -55.1 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -55.35 | |||||
Operating Margin % | -7262.89 | |||||
Net Margin % | -7207.55 | |||||
ROE % | -103.54 | |||||
ROA % | -94.03 | |||||
ROIC % | -1474.84 | |||||
ROC (Joel Greenblatt) % | -2461.34 | |||||
ROCE % | -101.62 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 167.27 | |||||
PB Ratio | 2.27 | |||||
Price-to-Tangible-Book | 2.3 | |||||
EV-to-EBIT | -1.5 | |||||
EV-to-EBITDA | -1.51 | |||||
EV-to-Revenue | 108.1 | |||||
EV-to-Forward-Revenue | 5.54 | |||||
EV-to-FCF | -1.66 | |||||
Price-to-Net-Current-Asset-Value | 2.39 | |||||
Price-to-Net-Cash | 2.49 | |||||
Earnings Yield (Greenblatt) % | -66.67 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NAS:NMTC
Executives
EMBED
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.159 | ||
EPS (TTM) ($) | -0.84 | ||
Beta | 1.17 | ||
Volatility % | 102.33 | ||
14-Day RSI | 74.8 | ||
14-Day ATR ($) | 0.172355 | ||
20-Day SMA ($) | 1.391005 | ||
12-1 Month Momentum % | -78.34 | ||
52-Week Range ($) | 0.5101 - 6.8 | ||
Shares Outstanding (Mil) | 16.19 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
NeuroOne Medical Technologies Corp Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |